title: Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs.
abstract: The present study aimed to establish hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate (step hot-GINF HEC) for assessment of acute insulin resistance in anesthetized pigs and to arrange for combination with invasive investigative methods. Tracer enrichment was measured during D-[6,6-(2)H(2)]glucose infusion before and after surgical instrumentation (n = 8). Insulin dose-response characteristics were determined by two step hot-GINF HEC procedures, with accordingly labeled glucose infusates performed at a total of six insulin infusion rates ranging from 0.2 to 2.0 mU kg(-1) min(-1) (n = 8). Finally, three-step hot-GINF HEC (0.4, 1.2, and 2.0 mU kg(-1) min(-1)) was performed subsequent to major surgical trauma (n = 8). Tracer enrichment, basal glucose kinetics, and circulating levels of C-peptide, cortisol, glucagon, and catecholamines were not influenced by surgical instrumentation. Mean intraindividual coefficient of variance levels for glucose infusion rates and repeatedly measured insulin, glucose, and tracer enrichment indicated stable clamping conditions. Basal and maximal insulin-stimulated glucose utilization was twice as high as in humans at approximately 5.5 and 21 mg kg(-1) min(-1). Surgical trauma elicited pronounced peripheral and moderate hepatic insulin unresponsiveness (45% lower whole body glucose disposal and 19% less suppressed endogenous glucose release) and apparently diminished metabolic insulin clearance. Step hot-GINF HEC seems suitable for assessment of acute insulin resistance in anesthetized pigs, and combination with invasive investigative methods requiring surgical instrumentation can be accomplished without the premises for utilization of the technique being altered, but attention must be paid to alterations in metabolic insulin clearance.
authors.affiliation: Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway. petter.fosse.gjessing@unn.no
authors.forename: Petter Fosse
authors.initials: PF
authors.lastname: Gjessing
authors.forename: Ole-Martin
authors.initials: OM
authors.lastname: Fuskevåg
authors.forename: Martin
authors.initials: M
authors.lastname: Hagve
authors.forename: Arthur
authors.initials: A
authors.lastname: Revhaug
authors.forename: Øivind
authors.initials: Ø
authors.lastname: Irtun
mesh_terms: D000818:Animals; D002096:C-Peptide / Q000097:blood; D002853:Chromatography, Liquid; D004305:Dose-Response Relationship, Drug; D005934:Glucagon / Q000097:blood; D005947:Glucose / Q000008:administration & dosage* / Q000378:metabolism; D015309:Glucose Clamp Technique / Q000379:methods*; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007333:Insulin Resistance / Q000502:physiology*; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D013552:Swine / Q000097:blood / Q000378:metabolism* / Q000601:surgery; D053719:Tandem Mass Spectrometry
chemical_list: D002096:C-Peptide; D007328:Insulin; D005934:Glucagon; D005947:Glucose; D006854:Hydrocortisone